Summary
Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers. The suppression of cell motility by MRP-1/CD9 may cause suppression of the metastasis. As we could not find any reports concerning the expression of MRP-1/CD9 and KAI1/CD82 in oesophageal cancers we investigated their expression in oesophageal specimens. We conducted immunohistochemical staining for MRP-1/CD9 against 108 cases of oesophageal squamous cell carcinoma using anti-MRP-1/CD9 monoclonal antibody M31-15, and for KAI1/CD82 against 104 cases using anti-KAI1/CD82 monoclonal antibody C33. To investigate the gradual expression of MRP-1/CD9 and KAI1/CD82, 24 oesophageal dysplasias were immunohistochemically stained using the same method and then investigated.
The expression of both MRP-1/CD9 and KAI1/CD82 were positive on the cell membranes of normal oesophageal epithelial cells, but reduced or negative in the cancer cells. Reduced MRP-1/CD9 expressions significantly correlated to tumour depth (P = 0.0009). We found a significantly greater number of reduced or negative expression of MRP-1/CD9 and KAI1/CD82 in lymph node metastatic cases (P = 0.0003 and P = 0.0129, respectively), but not in distant metastatic cases. The 5-year survival rate of MRP-1/CD9-negative and reduced patients was significantly worse than those of positive patients (n = 108, curative cases, RO). Few cases remained KAI1/CD82-positive (9.6%; 10/104) in oesophageal cancer. Twenty (83.3%) and twenty-two (91.7%) cases out of 24 dysplasias were defined as KAI1/CD82-positive and MRP-1/CD9-positive, respectively. The decrease in MRP-1/CD9 and KAI1/CD82 expression may facilitate lymph node metastasis in oesophageal squamous cell carcinomas. Knowing the status of the expression of MRP-1/CD9 appears helpful in predicting the prognosis for each patient.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adachi, M., Taki, T., Ieki, Y., Huang, C. L., Higashiyama, M. & Miyake, M. (1996). Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res, 56: 1751–1755.
Boucheix, C., Benoit, P., Frachet, P., Billard, M., Worthington, R. E., Gagnon, J. & Uzan, G. (1991). Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem, 266: 117–122.
Cajot, J. F., Sordat, I., Silvestre, T. & Sordat, B. (1997). Differential display cloning identifies motility-related protein (MRP-1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res, 57: 2593–2597.
Dong, J. T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Issac, J. T. & Barrett, J. C. (1995). KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 268: 884–886.
Dong, J. T., Suzuki, H., Pin, S. S., Bova, G. S., Schalken, J. A., Issacs, W. B., Barrett, J. C. & Issacs, J. T. (1996). Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res, 56: 4387–4390.
Hakomori, S. (1989). Aberrant glycolation in tumors and tumor-associated carbohydrate antigen. In Advances in Cancer Research, Vande-Woude GF, Klein G (eds), pp. 257–331, Academic Press: San Diego
Hato, T., Ikeda, K., Yasukawa, M., Watanabe, A. & Kobayashi, Y. (1988). Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen. Blood, 72: 224–229.
Hermanek, P. & Sobin, L. H. (1987). TNM classification of malignant tumours, 4th edn, pp 40–42, Springer Verlag: Berlin
Higashihara, M., Takahata, K., Yatomi, Y., Nakahara, K. & Kurokawa, K. (1990). Purification and partial characterization of CD9 antigen of human platelets. FEBS, 264: 270–274.
Higashiyama, M., Taki, T., Ieki, Y., Adachi, M., Huang, C. L., Koh, T., Kodama, K., Doi, O. & Miyake, M. (1995). Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res, 55: 6040–6044.
Higashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M. & Mekada, E. (1995). The membrane protein CD9/DRAP 27 potentiates the jutacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol, 128: 929–938.
Ikeyama, S., Koyama, M., Yamaoko, M., Sasada, R. & Miyake, M. (1993). Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med, 177: 1231–1237.
Imamura, M., Ohishi, K., Mizutani, N., Yanagibashi, K., Naito, M., Shimada, Y., Hattori, Y., Satomura, K. & Tobe, T. (1987). Retrosternal esophagogastrostomy with EEA stapler after subtotal resection of the esophagus: application and results. Dig Surg, 4: 101–105.
Miyake, M., Koyama, M., Seno, M. & Ikeyama, S. (1991). Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med, 174: 1347–1354.
Miyake, M., Nakano, K., Ieki, Y., Adachi, M., Huang, C. L., Itoi, S., Koh, T. & Taki, T. (1995). Motility-related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res, 55: 4127–4131.
Nakamura, K., Iwamoto, R. & Mekada, E. (1995). Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP 27)/CD9 form a complex with integrin α3β1 at cell–cell contact sites. J Cell Biol, 129: 1691–1705.
Ueda, T., Ichikawa, T., Tamaru, J., Mikata, A., Akakura, K., Akimoto, S., Imai, T., Yoshie, O., Shiraishi, T., Yatani, R., Ito, H. & Shimazaki, J. (1996). Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am J Pathol, 149: 1435–1440.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Uchida, S., Shimada, Y., Watanabe, G. et al. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 79, 1168–1173 (1999). https://doi.org/10.1038/sj.bjc.6690186
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690186
Keywords
This article is cited by
-
Endocytosis: a pivotal pathway for regulating metastasis
British Journal of Cancer (2021)
-
Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population
Medical Oncology (2013)
-
CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth
British Journal of Cancer (2011)
-
Tetraspanins and tumor progression
Clinical & Experimental Metastasis (2011)
-
A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
Journal of Gastroenterology (2009)